同期大直径自发性门体分流道栓塞预防TIPS术后显性肝性脑病:一项随机对照试验
该随机对照试验纳入56例因食管胃静脉曲张出血拟行TIPS且存在大直径自发性门体分流道的肝硬化患者,1:1分为单纯TIPS组(29例)与TIPS联合同期分流道栓塞组(27例)。中位随访24个月,联合组显性肝性脑病累积发生率显著低于单纯TIPS组(21.2% vs 48.3%;HR 0.38;95%CI 0.15-0.97;p=0.043),两组再出血、分流道功能障碍、死亡及其他不良事件无显著差异。
要点
- TIPS联合同期大直径自发性门体分流道栓塞可降低显性肝性脑病风险。
- 2年显性肝性脑病累积发生率联合组21.2% vs 单纯TIPS组48.3%(HR 0.38;95%CI 0.15-0.97;p=0.043)。
- 两组再出血、分流道功能障碍、死亡及其他不良事件无显著差异。
核心结论
- 在因静脉曲张出血接受TIPS的肝硬化患者中,同期大直径自发性门体分流道栓塞降低了显性肝性脑病风险且未增加其他并发症。
- 作者认为,应考虑同期大直径自发性门体分流道栓塞以预防TIPS术后肝性脑病。
研究设计与样本
- 随机对照试验,2014年6月至2017年8月纳入56例因预防静脉曲张出血拟行TIPS且存在大直径自发性门体分流道的肝硬化患者。
- 按1:1随机分为单纯TIPS组(n=29)与TIPS联合同期自发性门体分流道栓塞组(n=27)。
- 主要终点为显性肝性脑病,中位随访24个月。
主要发现
- 主要终点在单纯TIPS组15例(51.7%)与联合组6例(22.2%)发生(p=0.045)。
- 2年显性肝性脑病累积发生率联合组21.2% vs 单纯TIPS组48.3%(HR 0.38;95%CI 0.15-0.97;p=0.043)。
- 2年再出血发生率联合组15.4% vs 单纯TIPS组25.1%(p=0.522),无显著差异。
- 2年分流道功能障碍发生率联合组12.3% vs 单纯TIPS组18.6%(p=0.593),无显著差异。
- 2年死亡率联合组15.0% vs 单纯TIPS组6.9%(p=0.352),无显著差异。
关键数值与推荐
- 主要终点为显性肝性脑病。
- TIPS置入及自发性门体分流道栓塞在所有患者中均成功。
临床怎么用
- 作者认为,对于因静脉曲张出血接受TIPS的肝硬化患者,应考虑同期大直径自发性门体分流道栓塞以预防TIPS术后肝性脑病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Large spontaneous portosystemic shunt (SPSS) is associated with increased risk of HE in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS). This study aimed to evaluate whether prophylactic embolization of large SPSS at the time of TIPS creation could reduce the incidence of post-TIPS HE in patients with cirrhosis and variceal bleeding. APPROACH AND RESULTS: From June 2014 to August 2017, 56 patients with cirrhosis and large SPSS planning to undergo TIPS for the prevention of variceal bleeding were randomly assigned (1:1) to receive TIPS alone (TIPS group, n = 29) or TIPS plus simultaneous SPSS embolization (TIPS+E group, n = 27). The primary endpoint was overt HE. TIPS placement and SPSS embolization was successful in all patients. During a median follow-up of 24 months, the primary endpoint was met in 15 patients (51.7%) in the TIPS group and six patients (22.2%) in the TIPS+E group (p = 0.045). The 2-year cumulative incidence of overt HE was significantly lower in the TIPS+E group compared with the TIPS group (21.2% vs. 48.3%; HR, 0.38; 95% CI, 0.15-0.97; p = 0.043). The 2-year incidence of recurrent bleeding (TIPS+E vs. TIPS, 15.4% vs. 25.1%; p = 0.522), shunt dysfunction (12.3% vs. 18.6%, p = 0.593), death (15.0% vs. 6.9%, p = 0.352), and other adverse events was not significantly different between the two groups. CONCLUSIONS: In patients with cirrhosis treated with TIPS for variceal bleeding, concurrent large SPSS embolization reduced the risk for overt HE without increasing other complications. Concurrent large SPSS embolization should therefore be considered for prophylaxis of post-TIPS HE.
引用
- Lv Y, Chen H, Luo B, et al. Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial. Hepatology. 2022. PMID: 35266571. doi:10.1002/hep.32453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。